tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Mills, 157 are a BUY (83.96%), 28 are a HOLD (14.97%), 2 are a SELL (1.07%).
Analyst Jason Mills, currently employed at CANACCORD, carries an average stock price target met ratio of 80.6% that have a potential upside of 22.53% achieved within 197 days.
Jason Mills’s has documented 367 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PEN, Penumbra at 08-May-2024.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for VAPO (VAPOTHERM) at 3/5/2020. The price target of $112 was fulfilled within 11 days with a profit of $30.8 (37.93%) receiving and performance score of 34.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
90
$12.44 (16.04%)
66
10 days ago
8/9 (88.89%)
$11.86 (15.18%)
175
Buy
86
$8.44 (10.88%)
77
10 days ago
16/17 (94.12%)
$7.86 (10.06%)
459
Buy
84
$6.44 (8.30%)
70
11 days ago
13/14 (92.86%)
$5.98 (7.66%)
367
Buy
81
$3.44 (4.44%)
72
24 days ago
9/10 (90%)
$4.45 (5.81%)
98
Buy
82
$4.44 (5.72%)
82
1 months 8 days ago
20/22 (90.91%)
$5.69 (7.46%)
319
Which stock is Jason Mills is most bullish on?
What Year was the first public recommendation made by Jason Mills?
